InterMune Pharmaceuticals

InterMune, Inc., is a biopharmaceutical company focused on developing and commercializing innovative therapies in hepatology and pulmonology. We market Actimmune® (interferon gamma-1b), approved for the treatment of severe, malignant osteopetrosis and chronic granulomatous disease. We have a late-stage and preclinical development pipeline in the areas of pulmonology and hepatology. In pulmonology, we are developing two therapies for the treatment of idiopathic pulmonary fibrosis (IPF): interferon gamma-1b and pirfenidone. In hepatology, we are focused on expanding treatment options for patients suffering from HCV infections. We have identified and characterized several highly potent preclinical HCV protease inhibitor candidates and are rapidly progressing one of them through toxicology and other IND-enabling activities. In addition, we are pursuing research related to other small molecules for unspecified hepatology targets.

Contact Details: 3280 Bayshore Blvd. Brisbane CA 94005 United States of America Tel: (415) 466-2200 Fax: (415) 466-2300 Email: ir@intermune.com WWW: www.intermune.com/

Loading...

Recent Publications by InterMune Pharmaceuticals:
Pleural involvement in chronic sarcoidosis detected by thoracic CT scanning. BACKGROUND AND AIM: 5-10% of patients with sarcoidosis exhibit pleural...	13th July, 2005	Intermune Pharmaceuticals,	Sarcoidosis Vasc Diffuse Lung Dis. 2005 Mar;22(1):58-62.
Developing non-viral DNA delivery systems for cancer and infectious disease. Efforts to deliver therapeutic genes are frequently rebuffed by the body's...	15th February, 2001	InterMune Pharmaceuticals, CA-94010, Burlingame, USA	Drug Discov Today. 2001 Feb 1;6(4):186-197.

BioNews Results for InterMune Pharmaceuticals:
TRIN Pharma names Stefan Wohlfeil CEO	FierceBiotech:  Nov 11 2009 3:49PM Matching: intermune pharmaceuticals
InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone	Healthcare Sales & Marketing Network:  Nov 8 2009 7:33PM Matching: intermune pharmaceuticals
InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone	PR Newswire via Yahoo!:  Nov 5 2009 2:13PM Matching: intermune pharmaceuticals
InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone	SmartBrief:  Nov 5 2009 4:44PM Matching: intermune pharmaceuticals
InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone	RBC Dain Rauscher:  Nov 5 2009 1:51PM Matching: intermune pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution	→View more InterMune Pharmaceuticals news.

InterMune Pharmaceuticals (ITMN) Financial information Links from Barchart
ITMN Quote from from Barchart.com
ITMN Chart from from Barchart.com
ITMN Profile from from Barchart.com
ITMN Opinion from from Barchart.com
→View more InterMune Pharmaceuticals finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 396 times since April 2007, the link to the organisation's website has been followed 51 times

Recent Search Terms used to find this page: intermune pharma | intermune pharmaceuticals | .

Search for more companies in Brisbane

Search for more companies in CA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for InterMune Pharmaceuticals